跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACARIZAX ORAL LYOPHILISATE 12 SQ-HDM - PPB Drug Approval Details
Approvals
/
PPB
/
ACARIZAX ORAL LYOPHILISATE 12 SQ-HDM
Approved
STANDARD
ACARIZAX ORAL LYOPHILISATE 12 SQ-HDM
ABBOTT LAB LTD
🇰🇪 Pharmacy and Poisons Board
Approval Date
Jun 21, 2024
Approval ID
e3bbb16d8c3e7749
Company
ABBOTT LAB LTD
Type
Standard
Approval Details
Approval Id
e3bbb16d8c3e7749
Product Name
ACARIZAX ORAL LYOPHILISATE 12 SQ-HDM
Drug Hk Name
ACARIZAX ORAL LYOPHILISATE 12 SQ-HDM
Registration Code
HK-65924
Company Name
ABBOTT LAB LTD
Company Detail Path
/organization/abbott-laboratories-ltd
Registration Category
Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement
Prescription only Medicines
Registration Date
2018-10-03
Company Address
ROOM 2401-3 & 9, 19-20/F AIA TOWER, 183 ELECTRIC RD, NORTH POINT, HONG KONG
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Jun 21, 2024
Approval ID
e3bbb16d8c3e7749
Type
Standard
Back to PPB Approvals